Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
•Download as PPTX, PDF•
2 likes•997 views
Student Biology Seminar Class presentation based on peer reviewed journal that breaks down the journal in various components for a more elusive understanding on whether Implantable Cardioverter- defibrillators provides efficacy for young children with heart conditions that lead up to Sudden Cardiac Death.
Report
Share
Report
Share
Recommended
Cad and ckd by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Intervention...
Cad and ckd by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interventional Cardiologist, Nagpur, MH, India
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...
This is a journal critical appraisal taken from Zhou et al. BMC Neurology 2014, 14:172
http://www.biomedcentral.com/1471-2377/14/172
Nicola batrick trauma
1. Trauma in the elderly often results from falls rather than traffic collisions. Falls are commonly due to age-related factors like weakness, visual impairment, balance issues, or cognitive decline.
2. Trauma protocols should be modified for elderly patients, including lowering thresholds for imaging and considering falls from standing as criteria for trauma activation.
3. Evaluating and managing elderly trauma patients requires considering pre-existing conditions, medications, functional status, and risk of issues like delirium. Thorough evaluation and protocols help optimize care of the complex elderly trauma patient.
pacemaker
IN this PPT I talk about :
what is the pacemaker, types of pacemaker, complication of it, and nursing management for patient with pacemaker.
JOURNAL : Incidence of and Risk Factors for Sudden Cardiac Death in Children ...
Journal Critical
TITLE WITH
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy
Algorismo
Este documento proporciona instrucciones sobre cómo comunicar la carga académica de profesores. Revisa si la persona está en planta docente o no, y si tiene carga académica asignada o no, y en base a eso determina si se debe comunicar la carga académica o no a través de correo electrónico.
Incidencia de la muerte súbita y la formación como pilar de la supervivencia ...
La muerte súbita es un problema de salud pública que causa entre 300,000 y 400,000 muertes al año en EEUU. Se propone educar a la población en masaje cardíaco y disponer de ambulancias equipadas con desfibriladores para tratar a pacientes en la vía pública, con el objetivo de reducir las tasas de mortalidad. Asimismo, se sugiere implementar pruebas genéticas y dispositivos portátiles de detección para identificar a personas en riesgo y brindarles atención médica oportuna
Difference between a pacemaker and an icd presentation
A pacemaker monitors and regulates abnormal heart rhythms with low-energy pulses, while an ICD provides higher-energy shocks to reset the heart during sudden cardiac arrest. Both devices have leads that connect to the heart, but ICD leads can deliver defibrillation shocks to treat life-threatening arrhythmias unlike pacemaker leads which only pace the heart.
Recommended
Cad and ckd by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Intervention...
Cad and ckd by Dr. Vaibhav Yawalkar MD DM Cardiology, Consultant Interventional Cardiologist, Nagpur, MH, India
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...
This is a journal critical appraisal taken from Zhou et al. BMC Neurology 2014, 14:172
http://www.biomedcentral.com/1471-2377/14/172
Nicola batrick trauma
1. Trauma in the elderly often results from falls rather than traffic collisions. Falls are commonly due to age-related factors like weakness, visual impairment, balance issues, or cognitive decline.
2. Trauma protocols should be modified for elderly patients, including lowering thresholds for imaging and considering falls from standing as criteria for trauma activation.
3. Evaluating and managing elderly trauma patients requires considering pre-existing conditions, medications, functional status, and risk of issues like delirium. Thorough evaluation and protocols help optimize care of the complex elderly trauma patient.
pacemaker
IN this PPT I talk about :
what is the pacemaker, types of pacemaker, complication of it, and nursing management for patient with pacemaker.
JOURNAL : Incidence of and Risk Factors for Sudden Cardiac Death in Children ...
Journal Critical
TITLE WITH
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy
Algorismo
Este documento proporciona instrucciones sobre cómo comunicar la carga académica de profesores. Revisa si la persona está en planta docente o no, y si tiene carga académica asignada o no, y en base a eso determina si se debe comunicar la carga académica o no a través de correo electrónico.
Incidencia de la muerte súbita y la formación como pilar de la supervivencia ...
La muerte súbita es un problema de salud pública que causa entre 300,000 y 400,000 muertes al año en EEUU. Se propone educar a la población en masaje cardíaco y disponer de ambulancias equipadas con desfibriladores para tratar a pacientes en la vía pública, con el objetivo de reducir las tasas de mortalidad. Asimismo, se sugiere implementar pruebas genéticas y dispositivos portátiles de detección para identificar a personas en riesgo y brindarles atención médica oportuna
Difference between a pacemaker and an icd presentation
A pacemaker monitors and regulates abnormal heart rhythms with low-energy pulses, while an ICD provides higher-energy shocks to reset the heart during sudden cardiac arrest. Both devices have leads that connect to the heart, but ICD leads can deliver defibrillation shocks to treat life-threatening arrhythmias unlike pacemaker leads which only pace the heart.
Sudden Cardiac Death and Arrythmias
This document discusses sudden cardiac death and arrhythmias in athletes. It provides information on:
1) The most common causes of exercise-related sudden death depend on age, with hypertrophic cardiomyopathy being the most common in young athletes under 35 years old.
2) While the risk of sudden death from exercise is low in healthy adults, it increases with certain cardiac conditions like coronary artery disease, structural heart diseases, and inherited arrhythmia syndromes.
3) Evaluation of athletes with arrhythmias or syncope requires careful examination, testing like ECGs, echocardiograms, and exercise testing to determine the cause and risk level to guide management decisions around activity restriction.
What is Atrial Fibrillation (afib)?
Atrial fibrillation (afib) is a heart rhythm disorder (arrhythmia). It increases your risk of having a stroke and can affect your quality of life. There are many treatment options for patients with atrial fibrillation (afib).
In order to decrease the burden of the symptoms from afib, we can use medications or procedures - catheter ablation.
Patients with afib have a 5 fold higher risk of having a stroke. Traditionally blood thinners are used to decrease that risk. A new option available as an alternative to blood thinners is the Watchman left atrial appendage closure device.
History of ICDs (Internal Cardiac Defibrillators)
ICDs have been available since the 80s for the prevention of sudden cardiac death. The advancements are quite amazing, with a reduction in size from >250cc to less than 40cc, ease of implantation, safety and longevity.
Pacemakers
Pacemakers provide electrical stimulation to cause cardiac contraction when intrinsic cardiac activity is slow or absent. Pacing systems consist of a pulse generator and leads placed in the heart. Permanent systems use endocardial leads inserted transvenously into the right atrium and/or ventricle. Temporary systems use external pulse generators connected to transvenous or transcutaneous leads. Pacemakers can operate in asynchronous or synchronous modes and are used to treat symptomatic bradycardia. Complications include failure to output or capture pacing stimuli, oversensing, undersensing, and infection.
Pacemaker
Temporary pacemakers are used to treat slow heart rates or heart block. They are inserted using the Seldinger technique into the internal jugular, subclavian, or femoral veins. A temporary pacemaker system includes leads that are placed in the heart and a pulse generator unit. Common complications include bleeding, infection, and pneumothorax. The unit has settings for rate, output, and sensitivity that must be tested and adjusted based on the patient's pacing and sensing thresholds.
Pacemaker basics
contains pacemaker components, nomenclature, electrical concepts, pacemaker timmings. Dont forget to leave a comment
Pacemaker Overview
The document provides an overview of pacemaker indications, functions, and operation. It discusses normal heart rhythm and conduction, abnormalities that can require pacing like sinus node dysfunction and AV block, pacemaker components, modes and how they work, factors in selecting an optimal pacing mode, and indications for various pacing therapies.
Cardiac Pacemaker
This document discusses cardiac pacemakers. It defines a pacemaker as a medical device that provides support to the heart's pacemaking system when it is not functioning adequately. It explains that pacemakers are needed when the sinoatrial node or atrioventricular node cannot generate a sufficient heartbeat. The document outlines the components of a pacemaker including electrodes, a power source, pulse generator, timing control, output driver, and sensing amplifier. It describes the different types of pacemakers such as internal, external, fixed rate, demand, and atrial or ventricular triggered models. Complications from pacemakers like pacemaker syndrome and embolism are also mentioned.
LinkedIn SlideShare: Knowledge, Well-Presented
70 million professionals use LinkedIn SlideShare to learn about any topic quickly and stand out.
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
This guideline from the American Heart Association/American Stroke Association provides recommendations for the management of patients with spontaneous intracerebral hemorrhage (ICH). It covers topics such as the epidemiology of ICH, mechanisms of injury, diagnosis and assessment, medical and intensive care treatment including blood pressure management and reversal of anticoagulation, surgical interventions, and rehabilitation. The guideline utilizes a classification system to grade recommendations by strength (Class I, II, or III) and level of evidence (Level A-C). It provides specific guidance on diagnostic evaluation, treatment of coagulopathy and antiplatelet therapy in ICH patients, and strategies for determining the etiology of ICH based on location and patient characteristics.
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
This guideline from the American Heart Association/American Stroke Association provides recommendations for the management of patients with spontaneous intracerebral hemorrhage (ICH). It covers topics such as the epidemiology of ICH, mechanisms of injury, diagnosis and assessment, medical and intensive care treatment including blood pressure management and reversal of anticoagulation, surgical interventions, and rehabilitation. The guideline utilizes a classification system to grade recommendations by strength (Class I, II, or III) and level of evidence (Level A-C). It provides specific guidance on diagnostic evaluation, treatment of coagulopathy and antiplatelet therapy in ICH patients, and strategies for determining the etiology of ICH based on location and patient characteristics.
[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...
CABG was associated with lower long-term mortality compared to PCI in patients with acute heart failure and coronary artery disease. The study analyzed 717 patients hospitalized for acute heart failure who received either CABG or PCI. Patients who received CABG had lower rates of all-cause death after discharge and revascularization compared to PCI. CABG was also associated with fewer rehospitalizations for cardiovascular issues. However, the study was limited by its observational design and inability to fully account for differences in patient characteristics between treatment groups.
Drug Development in Pediatric Heart Failure
This document discusses drug development for pediatric acute heart failure. There are several challenges including heterogeneous patient populations ranging from infants to older children with different conditions like cardiomyopathy or congenital heart disease. Currently approved drugs for acute heart failure in Europe include dobutamine, milrinone, epinephrine, and digoxin, but they were approved based on studies in adults and mechanisms of heart failure differ between pediatric and adult patients. Low cardiac output syndrome is a major issue following surgery for congenital heart defects, affecting 25-65% of patients, and studies have found milrinone may decrease the risk of low output. However, more research is needed due to diverse causes and presentations of pediatric acute heart failure.
RIESGO CARDIOMETABOLICO
Los fármacos recomendados para iniciar el tratamiento antihipertensivo en este paciente son:
- Candesartán: por su demostrada capacidad para disminuir la hipertrofia ventricular izquierda y reducir la proteinuria, lo que es importante dado que el paciente presenta diabetes e hipertrofia ventricular.
- Telmisartán: al igual que el candesartán, ha demostrado reducir la proteinuria en pacientes diabéticos. Además, posee efecto antioxidante y antiaterogénico que son beneficiosos en este tipo de pacientes.
- V
Brown
The document discusses strategies for preventing secondary strokes or TIAs, including evaluating the mechanism of the initial event, localizing symptoms to determine if they are anterior or posterior circulation, and initiating the best medical, surgical, or endovascular treatment based on findings; it also stresses the importance of aggressively controlling modifiable risk factors like hypertension, smoking, diabetes, and hyperlipidemia to reduce long-term risk of recurrence.
DCI SAH Mid Year Poster FINAL
This study aims to determine the incidence of delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (aSAH) receiving nimodipine, with or without phenytoin for seizure prophylaxis. Phenytoin may reduce nimodipine levels through a drug interaction. The retrospective study will analyze patient outcomes between January 2013 to August 2014 at a large teaching hospital. The primary endpoint is incidence of DCI with secondary endpoints including vasospasms, seizures, mortality and discharge neurological status.
Shroff A - AIMRADIAL 2014 - Same-day discharge
Shroff A - AIMRADIAL 2014 - Same-day dischargeInternational Chair on Interventional Cardiology and Transradial Approach
This document discusses same day discharge after elective percutaneous coronary intervention (PCI). It reviews the literature on criteria for selecting low-risk patients suitable for same day discharge. Studies show same day discharge is safe and feasible in properly selected patients and can provide significant cost savings compared to overnight admission. The document outlines one institution's protocol for same day discharge following radial PCI, including clinical, procedural, and socio-demographic criteria for patient selection. It emphasizes focusing on low risk patients, procedures, and clinical scenarios to safely implement a same day discharge program.Evaluation and management of spontaneous Intracerebral hemorrhage
Outline of medical and surgical management of intracerebra hemorrhage largely based on AHA guidelines
Management of HOCM
- Implantable cardioverter defibrillators (ICDs) are recommended for patients with hypertrophic cardiomyopathy (HCM) who have survived sudden cardiac arrest, have spontaneous sustained ventricular tachycardia, or meet certain high-risk criteria.
- Risk stratification should be performed at initial evaluation and periodically to determine ICD need based on factors like family history of sudden cardiac death and abnormal blood pressure response.
- For left ventricular outflow tract obstruction, beta blockers and calcium channel blockers are first-line medical therapies while septal myectomy or alcohol septal ablation are invasive options that provide long-term reduction in outflow gradient.
madit crt varsh.pptx
MADIT-CRT was a randomized controlled trial of 1820 patients with asymptomatic or mildly symptomatic heart failure that compared cardiac resynchronization therapy with a defibrillator (CRT-D) to an implantable cardioverter-defibrillator (ICD) alone. The trial found that among patients with left bundle branch block, CRT-D reduced the risk of the combined primary endpoint of death from any cause or a heart failure event by 57% compared to ICD alone. This benefit was driven by a 35% reduction in all-cause mortality and a 63% reduction in heart failure events. Based on these results, the FDA approved an expanded indication for CRT-D devices to include patients with left bundle branch
Hypertrophic cardiomyopathy state of the art
This document summarizes research on hypertrophic cardiomyopathy (HCM) conducted by Barry Maron and colleagues. Some key points:
1. Contemporary treatments like ICDs, septal myectomy, and medications have transformed HCM into a treatable disease with low mortality and potential for normal longevity.
2. Risk stratification models utilize factors like family history, abnormal blood pressure response, and late gadolinium enhancement on MRI to predict sudden cardiac death and guide ICD placement.
3. Recent data shows current HCM mortality may be half that of earlier cohorts, demonstrating the benefits of modern management strategies in reducing deaths from sudden cardiac death and heart failure.
PREGNANCY OUTCOMES IN WOMEN WITH hEART DISEASE
This document summarizes the results of the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India. The registry prospectively enrolled 1005 pregnant women with heart disease and their 1029 pregnancies from 2016-2019. It found that maternal cardiac events occurred in 15.2% of pregnancies, with heart failure being the most common. Maternal mortality was 1.9% overall but highest in women with prosthetic heart valves at 8.6%. Independent predictors of maternal cardiac events were left ventricular systolic dysfunction, prosthetic heart valves, severe mitral stenosis, pulmonary hypertension, and being diagnosed with heart disease for the first time during pregnancy. The modified WHO classification accurately predicted maternal cardiac events and
More Related Content
Viewers also liked
Sudden Cardiac Death and Arrythmias
This document discusses sudden cardiac death and arrhythmias in athletes. It provides information on:
1) The most common causes of exercise-related sudden death depend on age, with hypertrophic cardiomyopathy being the most common in young athletes under 35 years old.
2) While the risk of sudden death from exercise is low in healthy adults, it increases with certain cardiac conditions like coronary artery disease, structural heart diseases, and inherited arrhythmia syndromes.
3) Evaluation of athletes with arrhythmias or syncope requires careful examination, testing like ECGs, echocardiograms, and exercise testing to determine the cause and risk level to guide management decisions around activity restriction.
What is Atrial Fibrillation (afib)?
Atrial fibrillation (afib) is a heart rhythm disorder (arrhythmia). It increases your risk of having a stroke and can affect your quality of life. There are many treatment options for patients with atrial fibrillation (afib).
In order to decrease the burden of the symptoms from afib, we can use medications or procedures - catheter ablation.
Patients with afib have a 5 fold higher risk of having a stroke. Traditionally blood thinners are used to decrease that risk. A new option available as an alternative to blood thinners is the Watchman left atrial appendage closure device.
History of ICDs (Internal Cardiac Defibrillators)
ICDs have been available since the 80s for the prevention of sudden cardiac death. The advancements are quite amazing, with a reduction in size from >250cc to less than 40cc, ease of implantation, safety and longevity.
Pacemakers
Pacemakers provide electrical stimulation to cause cardiac contraction when intrinsic cardiac activity is slow or absent. Pacing systems consist of a pulse generator and leads placed in the heart. Permanent systems use endocardial leads inserted transvenously into the right atrium and/or ventricle. Temporary systems use external pulse generators connected to transvenous or transcutaneous leads. Pacemakers can operate in asynchronous or synchronous modes and are used to treat symptomatic bradycardia. Complications include failure to output or capture pacing stimuli, oversensing, undersensing, and infection.
Pacemaker
Temporary pacemakers are used to treat slow heart rates or heart block. They are inserted using the Seldinger technique into the internal jugular, subclavian, or femoral veins. A temporary pacemaker system includes leads that are placed in the heart and a pulse generator unit. Common complications include bleeding, infection, and pneumothorax. The unit has settings for rate, output, and sensitivity that must be tested and adjusted based on the patient's pacing and sensing thresholds.
Pacemaker basics
contains pacemaker components, nomenclature, electrical concepts, pacemaker timmings. Dont forget to leave a comment
Pacemaker Overview
The document provides an overview of pacemaker indications, functions, and operation. It discusses normal heart rhythm and conduction, abnormalities that can require pacing like sinus node dysfunction and AV block, pacemaker components, modes and how they work, factors in selecting an optimal pacing mode, and indications for various pacing therapies.
Cardiac Pacemaker
This document discusses cardiac pacemakers. It defines a pacemaker as a medical device that provides support to the heart's pacemaking system when it is not functioning adequately. It explains that pacemakers are needed when the sinoatrial node or atrioventricular node cannot generate a sufficient heartbeat. The document outlines the components of a pacemaker including electrodes, a power source, pulse generator, timing control, output driver, and sensing amplifier. It describes the different types of pacemakers such as internal, external, fixed rate, demand, and atrial or ventricular triggered models. Complications from pacemakers like pacemaker syndrome and embolism are also mentioned.
LinkedIn SlideShare: Knowledge, Well-Presented
70 million professionals use LinkedIn SlideShare to learn about any topic quickly and stand out.
Viewers also liked (9)
Similar to Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
This guideline from the American Heart Association/American Stroke Association provides recommendations for the management of patients with spontaneous intracerebral hemorrhage (ICH). It covers topics such as the epidemiology of ICH, mechanisms of injury, diagnosis and assessment, medical and intensive care treatment including blood pressure management and reversal of anticoagulation, surgical interventions, and rehabilitation. The guideline utilizes a classification system to grade recommendations by strength (Class I, II, or III) and level of evidence (Level A-C). It provides specific guidance on diagnostic evaluation, treatment of coagulopathy and antiplatelet therapy in ICH patients, and strategies for determining the etiology of ICH based on location and patient characteristics.
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
This guideline from the American Heart Association/American Stroke Association provides recommendations for the management of patients with spontaneous intracerebral hemorrhage (ICH). It covers topics such as the epidemiology of ICH, mechanisms of injury, diagnosis and assessment, medical and intensive care treatment including blood pressure management and reversal of anticoagulation, surgical interventions, and rehabilitation. The guideline utilizes a classification system to grade recommendations by strength (Class I, II, or III) and level of evidence (Level A-C). It provides specific guidance on diagnostic evaluation, treatment of coagulopathy and antiplatelet therapy in ICH patients, and strategies for determining the etiology of ICH based on location and patient characteristics.
[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...
CABG was associated with lower long-term mortality compared to PCI in patients with acute heart failure and coronary artery disease. The study analyzed 717 patients hospitalized for acute heart failure who received either CABG or PCI. Patients who received CABG had lower rates of all-cause death after discharge and revascularization compared to PCI. CABG was also associated with fewer rehospitalizations for cardiovascular issues. However, the study was limited by its observational design and inability to fully account for differences in patient characteristics between treatment groups.
Drug Development in Pediatric Heart Failure
This document discusses drug development for pediatric acute heart failure. There are several challenges including heterogeneous patient populations ranging from infants to older children with different conditions like cardiomyopathy or congenital heart disease. Currently approved drugs for acute heart failure in Europe include dobutamine, milrinone, epinephrine, and digoxin, but they were approved based on studies in adults and mechanisms of heart failure differ between pediatric and adult patients. Low cardiac output syndrome is a major issue following surgery for congenital heart defects, affecting 25-65% of patients, and studies have found milrinone may decrease the risk of low output. However, more research is needed due to diverse causes and presentations of pediatric acute heart failure.
RIESGO CARDIOMETABOLICO
Los fármacos recomendados para iniciar el tratamiento antihipertensivo en este paciente son:
- Candesartán: por su demostrada capacidad para disminuir la hipertrofia ventricular izquierda y reducir la proteinuria, lo que es importante dado que el paciente presenta diabetes e hipertrofia ventricular.
- Telmisartán: al igual que el candesartán, ha demostrado reducir la proteinuria en pacientes diabéticos. Además, posee efecto antioxidante y antiaterogénico que son beneficiosos en este tipo de pacientes.
- V
Brown
The document discusses strategies for preventing secondary strokes or TIAs, including evaluating the mechanism of the initial event, localizing symptoms to determine if they are anterior or posterior circulation, and initiating the best medical, surgical, or endovascular treatment based on findings; it also stresses the importance of aggressively controlling modifiable risk factors like hypertension, smoking, diabetes, and hyperlipidemia to reduce long-term risk of recurrence.
DCI SAH Mid Year Poster FINAL
This study aims to determine the incidence of delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (aSAH) receiving nimodipine, with or without phenytoin for seizure prophylaxis. Phenytoin may reduce nimodipine levels through a drug interaction. The retrospective study will analyze patient outcomes between January 2013 to August 2014 at a large teaching hospital. The primary endpoint is incidence of DCI with secondary endpoints including vasospasms, seizures, mortality and discharge neurological status.
Shroff A - AIMRADIAL 2014 - Same-day discharge
Shroff A - AIMRADIAL 2014 - Same-day dischargeInternational Chair on Interventional Cardiology and Transradial Approach
This document discusses same day discharge after elective percutaneous coronary intervention (PCI). It reviews the literature on criteria for selecting low-risk patients suitable for same day discharge. Studies show same day discharge is safe and feasible in properly selected patients and can provide significant cost savings compared to overnight admission. The document outlines one institution's protocol for same day discharge following radial PCI, including clinical, procedural, and socio-demographic criteria for patient selection. It emphasizes focusing on low risk patients, procedures, and clinical scenarios to safely implement a same day discharge program.Evaluation and management of spontaneous Intracerebral hemorrhage
Outline of medical and surgical management of intracerebra hemorrhage largely based on AHA guidelines
Management of HOCM
- Implantable cardioverter defibrillators (ICDs) are recommended for patients with hypertrophic cardiomyopathy (HCM) who have survived sudden cardiac arrest, have spontaneous sustained ventricular tachycardia, or meet certain high-risk criteria.
- Risk stratification should be performed at initial evaluation and periodically to determine ICD need based on factors like family history of sudden cardiac death and abnormal blood pressure response.
- For left ventricular outflow tract obstruction, beta blockers and calcium channel blockers are first-line medical therapies while septal myectomy or alcohol septal ablation are invasive options that provide long-term reduction in outflow gradient.
madit crt varsh.pptx
MADIT-CRT was a randomized controlled trial of 1820 patients with asymptomatic or mildly symptomatic heart failure that compared cardiac resynchronization therapy with a defibrillator (CRT-D) to an implantable cardioverter-defibrillator (ICD) alone. The trial found that among patients with left bundle branch block, CRT-D reduced the risk of the combined primary endpoint of death from any cause or a heart failure event by 57% compared to ICD alone. This benefit was driven by a 35% reduction in all-cause mortality and a 63% reduction in heart failure events. Based on these results, the FDA approved an expanded indication for CRT-D devices to include patients with left bundle branch
Hypertrophic cardiomyopathy state of the art
This document summarizes research on hypertrophic cardiomyopathy (HCM) conducted by Barry Maron and colleagues. Some key points:
1. Contemporary treatments like ICDs, septal myectomy, and medications have transformed HCM into a treatable disease with low mortality and potential for normal longevity.
2. Risk stratification models utilize factors like family history, abnormal blood pressure response, and late gadolinium enhancement on MRI to predict sudden cardiac death and guide ICD placement.
3. Recent data shows current HCM mortality may be half that of earlier cohorts, demonstrating the benefits of modern management strategies in reducing deaths from sudden cardiac death and heart failure.
PREGNANCY OUTCOMES IN WOMEN WITH hEART DISEASE
This document summarizes the results of the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India. The registry prospectively enrolled 1005 pregnant women with heart disease and their 1029 pregnancies from 2016-2019. It found that maternal cardiac events occurred in 15.2% of pregnancies, with heart failure being the most common. Maternal mortality was 1.9% overall but highest in women with prosthetic heart valves at 8.6%. Independent predictors of maternal cardiac events were left ventricular systolic dysfunction, prosthetic heart valves, severe mitral stenosis, pulmonary hypertension, and being diagnosed with heart disease for the first time during pregnancy. The modified WHO classification accurately predicted maternal cardiac events and
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
This document summarizes guidelines from the 2022 AHA/ACC/HFSA for the diagnosis and management of heart failure. It defines the stages of heart failure from A to D and discusses evaluation, causes, biomarkers, imaging, and invasive testing. Key recommendations include using biomarkers like BNP and NT-proBNP to diagnose and manage HF. Transthoracic echocardiography is recommended for initial evaluation, and cardiac MRI, CT, or nuclear imaging if echo is inadequate. Invasive procedures are not routinely recommended but may help in select cases. Remote monitoring can benefit some patients with advanced HF.
Koshy
This patient has a history of myocardial infarction, triple vessel coronary artery disease, and is scheduled for elective non-cardiac surgery. Based on his positive stress test results and coronary angiogram showing severe blockages, the cardiologist recommends coronary artery bypass graft surgery prior to the planned surgery to improve his long-term prognosis and reduce perioperative cardiac risks.
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
Guideline for the Management of Heart Failure Clinical Update
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
This document summarizes guidelines from the 2022 AHA/ACC/HFSA for the diagnosis and management of heart failure. It defines the stages of heart failure from A to D and discusses evaluation, causes, biomarkers, imaging, and invasive testing. Key recommendations include using biomarkers like BNP and NT-proBNP to diagnose and manage HF. Transthoracic echocardiography is recommended for initial evaluation, and cardiac MRI, CT, or nuclear imaging if echo is inadequate. Invasive procedures are not routinely recommended but may help in select cases. Remote monitoring can benefit some patients with advanced HF.
Trachtenberg surg onc risk icosna
General principal is that all patients with good functional capacity should proceed to surgery and coronary assessment should only be performed if the results would change management•For patients with recent MI, 2014 AHA/ACC guidelines recommend 3 month delay before stopping DAPT although anticipated updates may require only 1 month for newer DES•Several risk scores have been studied for risk MICA
Diabetes and heart two sides of the same coin
This ppt presented in a CME of doctors in March 2017 discusses-if all Diabetics should be treated aggressively for prevention of coronary artery disease & SHOULD IT BE PRESUMED AS IF THEY ARE ALREADY PATIENTS OF CAD?
This presentation is updated till March 2017
GLIMI IN T2DM CHF (1).pptx
Glimepiride use is associated with reduced cardiovascular mortality in patients with Type 2 diabetes and Chronic heart failure: a prospective study
This prospective study evaluated the effects of glimepiride treatment on clinical outcomes in patients with Type 2 diabetes and chronic heart failure. The study found that glimepiride was associated with reduced all-cause mortality, cardiovascular mortality, and hospitalizations for heart failure or acute myocardial infarction/stroke. Molecular docking and ELISA assays suggested that glimepiride may inhibit soluble epoxide hydrolase to increase cardioprotective epoxyeicosatrienoic acids, protecting the heart. Higher doses of glimepiride were associated with greater reduction in cardiovascular mortality and hospital
Similar to Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy (20)
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...
[Paper Report] Coronary Artery Bypass Graft versus Percutaneous Coronary In...
Evaluation and management of spontaneous Intracerebral hemorrhage
Evaluation and management of spontaneous Intracerebral hemorrhage
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
Recently uploaded
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
DECLARATION OF HELSINKI - History and principles
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
10 Benefits an EPCR Software should Bring to EMS Organizations
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
How to choose the best dermatologists in Indore.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Kosmoderma Academy Of Aesthetic Medicine
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Recently uploaded (20)
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
- 1. Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy Presented By: Jennifer Glen, Mi Hae Kim, Rosangel Vargas
- 2. Overview ● Objectives ● Background ● Methods ● Results ● Conclusion ● Critiques ● Q&A
- 3. Objective ● To determine the efficacy of ICDs in children and adolescents with HCM
- 4. Background ● What is HCM? ● HCM is the most common cause of SD in children and young adults
- 8. Abbreviations and Acronyms HCM - Hypertrophic Cardiomyopathy ICD - Implantable Cardioverter Defibrillator LV - Left Ventricle LVH - Left Ventricular Hypertrophy SD - Sudden Death VF - Ventricular Fibrillation VT - Ventricular Tachycardia
- 9. Methods ● Patient Selection ● Defibrillators ● Risk Factor Analysis
- 10. Results ● Baseline Characteristics ● ICD interventions /Timing ● Drugs ● Risk Factor Analysis
- 17. Discussion ● History of HCM Studies ● In this study… o Children and Adolescents ( < 20 years ) o Effective 20 % ( ≈ 90% with No or mild Symptoms) ● Who gets ICD among HCM patients o Extreme LVH o Syncope o Family History o Hypotensive BP response to exercise
- 20. Conclusion ● Successful ! ● Pros and Cons
- 22. Reference Maron BJ, Spirito P, Ackerman MJ, Casey SA,Semsarian C, Estes M, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS,Link MS. 2013. Prevention of Sudden Cardiac Death With Implantable Cardioverter- Defilbrillators in Children and Adolescents With Hypertrophic Cardiomyopathy. Journal of American College of Cardiology (No.14) [Internet]. [2013 April 09, cited 2015 March 13] Vol. 61. Available from: http://content.onlinejacc.org/mobile/article.aspx?articleid=1673454
- 23. Questions?